Public Comments to Agencies | Page 8 | Citizens Against Government Waste

Public Comments to Agencies

Agency Comments

Reply Comments Regarding the FCC's Privacy Rules

BEFORE THE FEDERAL COMMUNICATIONS COMMISSION Washington, D.C. In the Matter of Protecting the Privacy of Customers of Broadband and Other Telecommunications Services WC Docket No. 16-106 Reply Comments of 

Deborah Collier March 20, 2017
Agency Comments

Comments to FDA on Labeling for Biosimilar Products

May 31, 2016   Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852.   Re: Docket No. FDA-2016-D-0643 “Labeling for Biosimilar Products; Draft Guidance for Industry”  

Rachel Cole May 31, 2016
Agency Comments

FCC Comments on Protecting the Privacy of Customers of Broadband and Other Telecommunications Services

[PDF Download]  

CAGW Staff May 26, 2016
Agency Comments

Public Comments on FCC AllVid Proposal

  Sections: [Introduction] | [Government Technology Mandates] [Market Competition] | [Abrogation of Intellectual Property Rights]

CAGW Staff April 20, 2016
Agency Comments

Comments to the FCC regarding the Regulatory Status of Mobile Messaging Services (WT Docket No. 08-7)

Before the FEDERAL COMMUNICATIONS COMMISSION Washington, D.C.  20554   In the matter of  

Deborah Collier December 6, 2018
Agency Comments

CCAGW Sends Letter to CMS Admin. Marilyn Tavenner Regarding Part D Draft Guidance

October 24, 2014 The Honorable Marilyn Tavenner Administrator Centers for Medicare and Medicaid Services Department of Health and Human Services 200 Independence Avenue Washington, D.C.  20201   Dear Administrator Tavenner,

Curtis Kalin October 27, 2014
Agency Comments

Comments to FDA on Biosimilars

Margaret A. Hamburg, M.D. Commissioner Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993-0002 Dear Commissioner Hamburg,

CAGW Staff June 30, 2016


Sign Up For Email Updates

Optional Member Code